Natco Pharma invested an additional US$ 14 million in eGenesis, Inc., bringing its total investment to US$ 22 million. eGenesis pioneers genome engineering for transplantable organs, addressing global organ shortages.

Natco Pharma LimitedNATCOPHARM · Filed with the exchange